Allstate's price surge today seems to be confirming the bullish analyst outlook on the stock. Ending the day at $176.69, ALL has posted 3.5% gains, pushing the valuation of the stock even higher. Might the stock be overvalued, despite its buy rating?
Allstate has a P/E ratio of 38.6 based on its 12 month trailing earnings per share of $4.58. Considering its future earnings estimates of $17.41 per share, the stock's forward P/E ratio is 10.1. In comparison, the average P/E ratio of the Finance sector is 19.48 and the average P/E ratio of the S&P 500 is 28.21.
Allstate's P/E ratio tells us how much investors are willing to pay for each dollar of the company's earnings. The problem with this metric is that it doesn't take into account the expected growth in earnings of the stock. Sometimes elevated P/E ratios can be justified by equally elevated growth expectations.
We can solve this inconsistency by dividing the company's trailing P/E ratio by its five year earnings growth estimate, which in this case gives us a 0.13 Price to Earnings Growth (PEG) ratio. In ALL's case, the elevated P/E ratio is justified by future earnings growth estimates -- assuming those estimates turn out to be close to reality.
We can also compare the ratio of Allstate's market price to its book value, which gives us the price to book, or P/B ratio. A company's book value refers to its present equity value -- or what is left over when we subtract its liabilities from its assets. ALL has a P/B ratio of 2.8, with any figure close to or below one indicating a potentially undervalued company.
A comparison of the share price versus company earnings and book value should be balanced by an analysis of the company's ability to pay its liabilities. One popular metric is the Quick Ratio, or Acid Test, which is the company's current assets minus its inventory and prepaid expenses divided by its current liabilities. Allstate's quick ratio is 0.236. Generally speaking, a quick ratio above 1 signifies that the company is able to meet its liabilities.
The final element of our analysis will touch on Allstate's ability to generate cash for the benefit of its shareholders or for reinvesting in the business. For this, we look at the company's levered free cash flow, which is the sum of all incoming and outgoing cash flows, including the servicing of current debt and liabilities. Allstate has a free cash flow of $3.96 Billion, which it uses to pay its shareholders a 2.1% dividend.
By most metrics, Allstate is an overvalued stock. So why are analysts giving it such a generous rating? It probably has to do with their perception of its strong growth potential, as represented by its low PEG ratio. For growth-oriented investors, ALL is represents an interesting opportunity despite its elevated valuation. They just need to be sure that the growth story will come true. We will continue to monitor the stock to see which thesis prevails.
